Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Ischemic Heart Disease

  Free Subscription

Articles published in PLoS Genet

Retrieve available abstracts of 6 articles:
HTML format
Text format

Single Articles

    October 2017
  1. PATERNOSTER L, Tilling K, Davey Smith G
    Genetic epidemiology and Mendelian randomization for informing disease therapeutics: Conceptual and methodological challenges.
    PLoS Genet. 2017;13:e1006944.
    PubMed     Text format     Abstract available

    June 2017
  2. BYARS SG, Huang QQ, Gray LA, Bakshi A, et al
    Genetic loci associated with coronary artery disease harbor evidence of selection and antagonistic pleiotropy.
    PLoS Genet. 2017;13:e1006328.
    PubMed     Text format     Abstract available

    May 2017
  3. MAGOSI LE, Goel A, Hopewell JC, Farrall M, et al
    Identifying systematic heterogeneity patterns in genetic association meta-analysis studies.
    PLoS Genet. 2017;13:e1006755.
    PubMed     Text format     Abstract available

    April 2017
  4. FOLKERSEN L, Fauman E, Sabater-Lleal M, Strawbridge RJ, et al
    Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease.
    PLoS Genet. 2017;13:e1006706.
    PubMed     Text format     Abstract available

    July 2016
  5. YANG W, Ng FL, Chan K, Pu X, et al
    Coronary-Heart-Disease-Associated Genetic Variant at the COL4A1/COL4A2 Locus Affects COL4A1/COL4A2 Expression, Vascular Cell Survival, Atherosclerotic Plaque Stability and Risk of Myocardial Infarction.
    PLoS Genet. 2016;12:e1006127.
    PubMed     Text format     Abstract available

    April 2016
  6. LU Q, Powles RL, Wang Q, He BJ, et al
    Integrative Tissue-Specific Functional Annotations in the Human Genome Provide Novel Insights on Many Complex Traits and Improve Signal Prioritization in Genome Wide Association Studies.
    PLoS Genet. 2016;12:e1005947.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.